Insys Therapeutics Inc (INSYQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -124,507 | -226,835 | 7,590 | 58,053 | 36,054 |
| Depreciation Amortization | 7,605 | 8,462 | 8,278 | 6,722 | 2,867 |
| Income taxes - deferred | N/A | 23,243 | -5,636 | -4,914 | -655 |
| Accounts receivable | 8,903 | -859 | 26,618 | -23,770 | -7,796 |
| Other Working Capital | 43,849 | 112,267 | 17,957 | 34,426 | 18,479 |
| Other Operating Activity | 8,161 | 23,060 | 4,097 | 31,761 | 1,636 |
| Operating Cash Flow | $-55,989 | $-60,662 | $58,904 | $102,278 | $50,585 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 104,472 | 98,448 | 96,009 | 36,643 | 8,195 |
| PPE Investments | -6,095 | -16,661 | -10,614 | -13,842 | -22,245 |
| Purchase Of Investment | -61,726 | -132,068 | -115,375 | -138,470 | -56,605 |
| Sale Of Investment | 16,747 | 32,471 | 7,948 | 25,492 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | 400 |
| Investing Cash Flow | $53,398 | $-17,810 | $-22,032 | $-90,177 | $-70,255 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,144 | 5,871 | 6,083 | 12,171 | 10,945 |
| Common Stock Repurchased | N/A | N/A | -16,099 | -16,459 | N/A |
| Other Financing Activity | 0 | -42 | -1,729 | 13,596 | 21,449 |
| Financing Cash Flow | $2,144 | $5,829 | $-11,745 | $9,308 | $32,394 |
| Beginning Cash Position | 31,999 | 104,642 | 79,515 | 58,106 | 45,382 |
| End Cash Position | 31,552 | 31,999 | 104,642 | 79,515 | 58,106 |
| Net Cash Flow | $-447 | $-72,643 | $25,127 | $21,409 | $12,724 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,989 | -60,662 | 58,904 | 102,278 | 50,585 |
| Capital Expenditure | -6,095 | -16,661 | -10,614 | -13,842 | -22,245 |
| Free Cash Flow | -62,084 | -77,323 | 48,290 | 88,436 | 28,340 |